Arch Coal, Inc. News, Arch Coal, Inc. Quote, ARCH Quote

Arch Coal, Inc. (NY:ARCH) Delayed: 134.83 --0 (-0%)

Prev. Close

$134.83

Today 6M 1Y 5Y

Open

$134.83

52 Wk High

$86.47

52 Wk Low

$59.05

Day High

$134.83

Day Low

$134.83

P/E

N/A

EPS

$0.00

Volume

Friends, Peers and Foes (?): ACHFF, CEIX, CART, ENOV, CNX (more...)

ALERTS | RSS

Jun 4, 2026 07:41 AM Arch Biopartners Featured in American Diabetes Association Thought Leadership Series at the 2026 Scientific Sessions in New Orleans
May 22, 2026 06:50 AM Arch Biopartners announces Royal Columbian Hospital has dosed its first patient in its Phase II cardiac surgery-associated AKI trial
Apr 30, 2026 07:00 AM Royal Columbian Hospital begins patient recruitment in Arch Biopartners’ Phase II trial of LSALT peptide targeting CS-AKI
Apr 2, 2026 05:45 AM Arch Biopartners raises $600,000 in private placement offering
Apr 2, 2026 05:45 AM Arch Biopartners Closes Non-Brokered Private Placement
Mar 30, 2026 06:03 AM Arch Biopartners arranges $600,000 private placement at $0.60 per share
Mar 30, 2026 06:03 AM Arch Biopartners Arranges Non-Brokered Private Placement
Mar 24, 2026 09:13 AM Arch Biopartners and the Fraser Health Authority enter into a Clinical Trial Agreement for the Phase II Cardiac Surgery-Associated AKI Trial
Feb 9, 2026 07:29 AM Arch Biopartners Scientists Publish New Data Linking the Cytokine IL-32 to Inflammation and Diabetic Kidney Disease
Dec 16, 2025 07:40 AM Arch Biopartners Announces Ethics Approval for St. Michael’s Hospital to Participate in the Phase II Cardiac Surgery-Associated AKI Trial for LSALT Peptide

Entities mentioned with ARCH

View All Entities